Research Article

Characteristics of Multidrug Resistant Shigella and Vibrio cholerae O1 Infections in Patients Treated at an Urban and a Rural Hospital in Bangladesh

Table 2

Multidrug resistant Shigella spp. and Vibrio cholerae O1 recovered from patients with diarrhea, Dhaka and Matlab, International Centre for Diarrhoeal Research Bangladesh (icddr,b), 2000–2012.

AntimicrobialsShigella spp.Vibrio cholerae
Dhaka; (%)Matlab; (%)OR (95% CI) Dhaka;
(%)
Matlab;
(%)
OR (95% CI)

AMP + NAL + TMST203 (55)301 (56)0.94 (0.72, 1.24) 0.715
AMP + NAL + MEC4 (1)19 (3)0.31 (0.09, 0.96) 0.040
AMP + NAL + CIP1 (0.3)20 (4)0.07 (0.00, 0.51) <0.001
AMP + TMST + MEC21 (4)
AMP + TMST + CIP18 (5)1 (0.2)28.10 (3.96, 567.52) <0.001
AMP + CIP + MEC24 (7)
AMP + TMST + AZI5 (1)
AMP + CIP + AZI2 (0.5)
AMP + MEC + AZI2 (0.5)
TMST + CIP + AZI3 (1)
TMST + MEC + AZI2 (0.3)
CIP + MEC + AZI1 (0.3)
NAL + CIP + MEC20 (4)
NAL + TMST + MEC4 (1)1 (0.2)6.01 (0.63, 141.61) 0.163
NAL + TMST + CIP22 (6)67 (12)0.48 (0.28, 0.82) 0.005
TMST + CIP + MEC3 (1)3 (1)1.49 (0.24, 9.27) 0.689
TET + TMST + FUR103 (10)89 (35)0.20 (0.14, 0.29) <0.001
TET + FUR + ERY1 (0.4)
TMST + FUR + ERY7 (1)17 (7)0.09 (0.03, 0.24) <0.001
TMST + FUR + CIP
TET + TMST + ERY38 (4)148 (58)0.03 (0.02, 0.04) <0.001
AMP + TMST + CIP + AZI7 (2)
AMP + TMST + MEC + AZI2 (1)
AMP + CIP + MEC + AZI1 (0.3)
AMP + CIP + NAL + AZI1 (0.3)
AMP + NAL + TMST + CIP19 (5)67 (12)0.39 (0.22, 0.68) <0.001
AMP + NAL + TMST + MEC3 (1)
AMP + NAL + CIP + MEC3 (1)4 (1)1.12 (0.20, 5.92) 1.000
AMP + CIP + TMST + MEC9 (3)
TMST + NAL + CIP + MEC1 (0.3)3 (1)0.49 (0.02, 5.32) 0.652
TMST + TET + ERY + FUR906 (86)
TMST + ERY + CIP + FUR1 (0.1)
TMST + TET + ERY + AZI1 (0.1)
AMP + TMST + NAL + CIP + MEC24 (7)16 (3)2.32 (1.16, 4.64) 0.014
AMP + TMST + CIP + MEC + AZI7 (1)
FUR + ERY + CIP + TMST + TET1 (0.4)

AMP: Ampicillin; AZI: azithromycin; CIP: ciprofloxacin; ERY: erythromycin; FUR: furazolidin; MEC: mecillinam; NAL: nalidixic acid; TET: tetracycline; TMST: trimethoprim-sulfamethoxazole.